Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4453202 | 1.00 | TSHR (0.35) | TSHRTP53EGLN1EGLN3HCAR2 | |
| SCHEMBL12282953 | 0.80 | — | — | |
| SCHEMBL4453195 | 0.79 | TSHR (0.36) | TSHRTP53EGLN1EGLN3HCAR2 | |
| SCHEMBL16680847 | 0.79 | TSHR (0.36) | TSHRTP53EGLN1EGLN3HCAR2 | |
| SCHEMBL4453193 | 0.79 | TSHR (0.36) | TSHRTP53EGLN1EGLN3HCAR2 | |
| SCHEMBL27977114 | 0.78 | NFE2L2 (0.48) | HCAR2 | |
| SCHEMBL4456566 | 0.78 | NFE2L2 (0.48) | HCAR2 | |
| SCHEMBL27977116 | 0.67 | — | — | |
| SCHEMBL15344654 | 0.65 | TSHR (0.42) | TSHRTP53EGLN1EGLN3HCAR2 | |
| SCHEMBL15344653 | 0.65 | TSHR (0.42) | TSHRTP53EGLN1EGLN3HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7482479-B2 | Production of cis-pellitorin and use as a flavouring | SYMRISE GMBH & CO., KG (DE) | 2009-01-27 | — | — | US | disclosed |
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | SYMRISE AG (DE) | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | NISCH, CYP8B1, DLAT | TSHR 4375/4885TP53 2837/4885EGLN1 882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.